Non-Small Cell Lung Cancer Treatment Market Size

Non-Small Cell Lung Cancer Treatment Market size was over USD 18.91 billion in 2023 and is likely to reach USD 88.45 billion by the end of 2036, witnessing around 12.6% CAGR during the forecast period i.e., between 2024-2036. In the year 2024, the industry size of non-small cell lung cancer treatment is assessed at USD 20.82 billion.

The rising prevalence of non-small cell lung cancer, along with the growing awareness about the disease are expected to fuel the progress of this market. The growth of the non-small cell lung cancer treatment market can also be attributed to factors such as the increase in share of smoking population and the greater exposure to toxins on a global level. According to the data collected from World Health Organization, in 2020, the estimated new cases and number of deaths from lung cancer globally, were 2.21 million and 1.80 million, respectively.